Combinatorial libraries against libraries for selecting neoepitope activation-specific antibodies

Proceedings of the National Academy of Sciences of the United States of America

Volumn 107, Issue 14, 2010, Pages 6252-6257

  Hu, Xuebo ^a   Kang, Sungkwon ^a   Lefort, Craig ^b   Kim, Minsoo ^b   Jin, Moonsoo M ^a  

^a Cornell University   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Antibody antagonist; Mac 1 integrin; Phage display; Yeast display

Indexed keywords

COMPLEMENT COMPONENT C3; FIBRINOGEN; FIBRONECTIN; INTERCELLULAR ADHESION MOLECULE 1;

ANTIBODY ISOLATION; ANTIBODY LIBRARY; ANTIBODY SPECIFICITY; ANTIGEN ANTIBODY REACTION; ARTICLE; COMBINATORIAL LIBRARY; NONHUMAN; PHAGE DISPLAY; PRIORITY JOURNAL; PROTEIN BINDING; SURFACE PLASMON RESONANCE; TWO HYBRID SYSTEM; YEAST; YEAST CELL;

ANTIBODY SPECIFICITY; CELL ADHESION; CELL MOVEMENT; EPITOPES; HUMANS; LIGANDS; MACROPHAGE-1 ANTIGEN; NEUTROPHIL ACTIVATION; NEUTROPHILS; PEPTIDE LIBRARY; SACCHAROMYCES CEREVISIAE;

EID: 77950912270     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0914358107     Document Type: Article

References (42)

1. Tsai CJ, Del Sol A, Nussinov R (2009) Protein allostery, signal transmission and dynamics: A classification scheme of allosteric mechanisms. Mol Biosyst 5:207-216.
2. Shimaoka M, et al. (2006) AL-57, a ligand-mimetic antibody to integrin LFA-1, reveals chemokine-induced affinity up-regulation in lymphocytes. Proc Natl Acad Sci USA 103:13991-13996. (Pubitemid 44452969)
3. Peer D, Zhu P, Carman CV, Lieberman J, Shimaoka M (2007) Selective gene silencing in activated leukocytes by targeting siRNAs to the integrin lymphocyte function-associated antigen-1. Proc Natl Acad Sci USA 104:4095-4100. (Pubitemid 47181584)
4. Diamond MS, Springer TA (1993) A subpopulation of Mac-1 (CD11b/CD18) molecules mediates neutrophil adhesion to ICAM-1 and fibrinogen. J Cell Biol 120:545-556.
5. Elemer GS, Edgington TS (1994) Monoclonal antibody to an activation neoepitope of alpha M beta 2 inhibits multiple alpha M beta 2 functions. J Immunol 152:5836-5844.
6. Lu C, Ferzly M, Takagi J, Springer TA (2001) Epitope mapping of antibodies to the C-terminal region of the integrin beta 2 subunit reveals regions that become exposed upon receptor activation. J Immunol 166:5629-5637. (Pubitemid 32374186)
7. Gao J, Sidhu SS, Wells JA (2009) Two-state selection of conformation-specific antibodies. Proc Natl Acad Sci USA 106:3071-3076.
8. Huang L, et al. (2006) Identification and characterization of a human monoclonal antagonistic antibody AL-57 that preferentially binds the high-affinity form of lymphocyte function-associated antigen-1. J Leukocyte Biol 80:905-914. (Pubitemid 44835909)
9. Eisenhardt SU, et al. (2007) Generation of activation-specific human anti-alphaMbeta2 single-chain antibodies as potential diagnostic tools and therapeutic agents. Blood 109:3521-3528.
10. Kretzschmar T, von Ruden T (2002) Antibody discovery: Phage display. Curr Opin Biotechnol 13:598-602.
11. Bowley DR, Jones TM, Burton DR, Lerner RA (2009) Libraries against libraries for combinatorial selection of replicating antigen-antibody pairs. Proc Natl Acad Sci USA 106:1380-1385.
12. Hynes RO (2002) Integrins: Bidirectional, allosteric signaling machines. Cell 110:673-687.
13. Yusuf-Makagiansar H, Anderson ME, Yakovleva TV, Murray JS, Siahaan TJ (2002) Inhibition of LFA-1/ICAM-1 and VLA-4/VCAM-1 as a therapeutic approach to inflammation and autoimmune diseases. Med Res Rev 22:146-167. (Pubitemid 34160583)
14. Shimaoka M, Springer TA (2004) Therapeutic antagonists and the conformational regulation of the beta2 integrins. Curr Top Med Chem 4:1485-1495. (Pubitemid 39317604)
15. Yonekawa K, Harlan JM (2005) Targeting leukocyte integrins in human diseases. J Leukocyte Biol 77:129-140. (Pubitemid 40315046)
16. Schwarz M, et al. (2006) Conformation-specific blockade of the integrin GPIIb/IIIa: A novel antiplatelet strategy that selectively targets activated platelets. Circ Res 99:25-33. (Pubitemid 44297052)
17. Lee JO, Rieu P, Arnaout MA, Liddington R (1995) Crystal structure of the A domain from the alpha subunit of integrin CR3 (CD11b/CD18). Cell 80:631-638.
18. Li R, Rieu P, Griffith DL, Scott D, ArnaoutMA (1998) Two functional states of the CD11b A-domain: Correlations with key features of two Mn2+-complexed crystal structures. J Cell Biol 143:1523-1534.
19. Shimaoka M, et al. (2003) Structures of the alpha L I domain and its complex with ICAM-1 reveal a shape-shifting pathway for integrin regulation. Cell 112:99-111. (Pubitemid 36106422)
20. Hu X, Kang S, Chen X, Shoemaker CB, Jin MM (2009) Yeast surface two-hybrid for quantitative in vivo detection of protein-protein interactions via the secretory pathway. J Biol Chem 284:16369-16376.
21. Boder ET, Wittrup KD (1997) Yeast surface display for screening combinatorial polypeptide libraries. Nat Biotechnol 15:553-557.
22. Jin M, et al. (2006) Directed evolution to probe protein allostery and integrin I domains of 200,000-fold higher affinity. Proc Natl Acad Sci USA 103:5758-5763.
23. Kieke MC, Cho BK, Boder ET, Kranz DM, Wittrup KD (1997) Isolation of anti-T cell receptor scFv mutants by yeast surface display. Protein Eng 10:1303-1310.
24. Rao BM, Driver I, Lauffenburger DA, Wittrup KD (2004) Interleukin 2 (IL-2) variants engineered for increased IL-2 receptor alpha-subunit affinity exhibit increased potency arising from a cell surface ligand reservoir effect. Mol Pharmacol 66:864-869. (Pubitemid 39319458)
25. Kim YS, Bhandari R, Cochran JR, Kuriyan J, Wittrup KD (2006) Directed evolution of the epidermal growth factor receptor extracellular domain for expression in yeast. Proteins 62:1026-1035. (Pubitemid 43364165)
26. Lee HW, et al. (2007) Inducing rigid local structure around the zinc-binding region by hydrophobic interactions enhances the homotrimerization and apoptotic activity of zinc-free TRAIL. Biochem Biophys Res Commun 362:766-772.
27. Xiong JP, Li R, Essafi M, Stehle T, Arnaout MA (2000) An isoleucine-based allosteric switch controls affinity and shape shifting in integrin CD11b A-domain. J Biol Chem 275:38762-38767. (Pubitemid 32009211)
28. McCleverty CJ, Liddington RC (2003) Engineered allosteric mutants of the integrin alphaMbeta2 I domain: structural and functional studies. Biochem J 372:121-127.
29. Dransfield I, Cabanas C, Craig A, Hogg N (1992) Divalent cation regulation of the function of the leukocyte integrin LFA-1. J Cell Biol 116:219-226.
30. Dranginis AM, Rauceo JM, Coronado JE, Lipke PN (2007) A biochemical guide to yeast adhesins: glycoproteins for social and antisocial occasions. Microbiol Mol Biol R 71:282-294.
31. Smith J, Kontermann RE, Embleton J, Kumar S (2005) Antibody phage display technologies with special reference to angiogenesis. Faseb J 19:331-341. (Pubitemid 40316521)
32. Shimaoka M, et al. (2001) Reversibly locking a protein fold in an active conformation with a disulfide bond: Integrin alphaL I domains with high affinity and antagonist activity in vivo. Proc Natl Acad Sci USA 98:6009-6014. (Pubitemid 32488184)
33. Zhang H, et al. (2008) An unusual allosteric mobility of the C-terminal helix of a high-affinity alphaL integrin I domain variant bound to ICAM-5. Mol Cell 31:432-437.
34. Hansson GK (2005) Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 352:1685-1695.
35. Libby P (2002) Inflammation in atherosclerosis. Nature 420:868-874.
36. Diamond MS, Garcia-Aguilar J, Bickford JK, Corbi AL, Springer TA (1993) The I domain is a major recognition site on the leukocyte integrin Mac-1 (CD11b/CD18) for four distinct adhesion ligands. J Cell Biol 120:1031-1043. (Pubitemid 23056308)
37. Harlan JM, Vedder NB, Winn RK, Rice CL (1991) Mechanisms and consequences of leukocyte-endothelial interaction. West J Med 155:365-369.
38. Curley GP, Blum H, Humphries MJ (1999) Integrin antagonists. Cell Mol Life Sci 56:427-441.
39. Stephens P, et al. (1995) KIM127, an antibody that promotes adhesion, maps to a region of CD18 that includes cysteine-rich repeats. Cell Adhes Commun 3:375-384. (Pubitemid 26059829)
40. Petruzzelli L, Maduzia L, Springer TA (1995) Activation of lymphocyte function-associated molecule-1 (CD11a/CD18) and Mac-1 (CD11b/CD18) mimicked by an antibody directed against CD18. J Immunol 155:854-866.
41. de Wildt RM, Mundy CR, Gorick BD, Tomlinson IM (2000) Antibody arrays for high-throughput screening of antibody-antigen interactions. Nat Biotechnol 18:989-994.
42. Elphick GF, et al. (2009) Recombinant human activated protein C inhibits integrin-mediated neutrophil migration. Blood 113:4078-4085.